This wiki has undergone a migration to Confluence found Here
Difference between revisions of "September 2016 Pharmacy WGM Agenda"
Jump to navigation
Jump to search
Line 71: | Line 71: | ||
** Overview of Template work | ** Overview of Template work | ||
* Hot Topics | * Hot Topics | ||
− | |||
* Approval of May 2016 WGM Minutes | * Approval of May 2016 WGM Minutes | ||
* FHIR Ballot Reconciliation | * FHIR Ballot Reconciliation | ||
Line 98: | Line 97: | ||
**Reaffirm HL7 Version 3 Standard: Medication; Knowledge-Based Query, R1 | **Reaffirm HL7 Version 3 Standard: Medication; Knowledge-Based Query, R1 | ||
* FHIR Ballot Reconciliation | * FHIR Ballot Reconciliation | ||
+ | * Reps | ||
+ | ** Tuesday Q2 O&O - not needed | ||
+ | **Thursday Q3 - Clinical Statement - not needed | ||
||John||Scott||TBD | ||John||Scott||TBD | ||
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
− | * Rep to O&O | + | * Rep to O&O - Not needed |
* Joint with FHIR Infrastructure | * Joint with FHIR Infrastructure | ||
* Topics TBD | * Topics TBD | ||
Line 108: | Line 110: | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
+ | * Action Items | ||
* FHIR Ballot Reconciliation | * FHIR Ballot Reconciliation | ||
||Marla||John||TBD | ||Marla||John||TBD | ||
Line 113: | Line 116: | ||
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||
* Send 1 Rep to Patient Care | * Send 1 Rep to Patient Care | ||
+ | * Discussion of ballot item re: harmonization of attribute name | ||
||NA||TBD||TBD | ||NA||TBD||TBD | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" |
Revision as of 19:29, 19 September 2016
Contents |
Related Links |
Agenda
Icons: